Trials / Completed
CompletedNCT02329353
Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers
Clinical And Microbiological Analysis Of Orally Administered Lactobacillus Probiotic Lozenges In Chronic Periodontitis Patients Among Smokers And Non-smokers And Its Correlation With Clinical Parameters - A Clinico-Microbiological Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Next Gen Pharma India Pvt. Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Periodontitis is one of the most common chronic inflammatory disease with the etiology of bacterial plaque and is associated with a number of putative bacterial species. The periodontal destruction is substantially mediated by the host, driven by the bacterial challenge. The presence of pathogenic bacteria with the absence of so-called "beneficial bacteria" and the susceptibility of the host are the main aetiological factors of periodontal diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactobacillus brevis CD2 Lozenges | Each lozenge contains not less than 1 billion Colony forming unit of Lactobacillus brevis CD2 |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-11-01
- Completion
- 2016-12-01
- First posted
- 2014-12-31
- Last updated
- 2017-01-10
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02329353. Inclusion in this directory is not an endorsement.